SAM
ZYME icon

Silphium Asset Management’s Zymeworks ZYME Stock Holding History

Silphium Asset Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-15,000
Closed -$436K – 90
2021
Q3 		$436K Buy
+15,000
New +$499K 0.17% 82

Other funds holding ZYME

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Silphium Asset Management's ZYME Position: Q4 2021 in Review

Silphium Asset Management sold out of Zymeworks (ZYME) in Q4 2021, closing a stake of 15,000 shares — an estimated $436K sold.

Silphium Asset Management first reported a position in ZYME in Q3 2021 and held it in 1 quarter. The position peaked at $436K in Q3 2021. 114 funds tracked by Wall St. Rank hold ZYME as of Q4 2021.

  • Silphium Asset Management reported no remaining Zymeworks position as of Q4 2021 after selling out during the quarter.
  • Silphium Asset Management sold 15,000 Zymeworks shares in Q4 2021, an estimated $436K.
  • Silphium Asset Management first reported a position in Zymeworks in Q3 2021 and held it in 1 quarter.
  • Silphium Asset Management's Zymeworks position peaked at $436K in Q3 2021.
  • 114 funds tracked by Wall St. Rank held Zymeworks as of Q4 2021.

Based on Silphium Asset Management's 13F filing for Q4 2021, filed 30 Jan 2025.